Location: Home
  • search
  • go
  • Relate News
  • 9/3/2018Boehringer Supports BeiGene in Its China NDA Submission for Tislelizum...
  • 8/31/2018Recent Executive Moves
  • 8/31/2018Financial-related Company News in Brief
  • 8/31/2018RootPath Raises $7M in Seedfunding Round Led by Sequoia China
  • 8/31/2018State Council Decides to Further Improve the National Essential Drug S...
  • 8/30/2018An American Pharmaceutical Entrepreneur Achieves Billionaire Status --...
  • 8/30/2018CDE issues General Requirements for Batch Sample Size of BE Studies
  • 8/30/2018Final Government Reorganization Plan Unveils Regulatory Roles of SAMR ...
  • 8/30/2018New English Name of China's Drug Watchdog Confirmed to be NMPA
  • 8/30/2018NYT: China Withholds H7N9 Bird Flu Sample
  • 8/29/2018Jacobio Pharma Raises $55M in Series C Round Financing
  • 8/29/2018Sinclair Pharma Embraces A Potential Acquisition Offer from Huadong
  • 8/29/2018State Council Issues Notice for Major Tasks of Healthcare Reform in H2...
  • 8/29/2018CStone's Anti-CTLA-4 Antibody CS1002 Receives IND Approval in China
  • 8/29/2018Ping An Good Doctor Ties Up with Jointown Pharma to Enpower Primary He...
  • 8/29/2018Bloomburg: Wall Street Expats Angle for Piece of China’s Biotech Drug...
  • 8/28/2018Premier Li Keqiang Orders Reinforced Healthcare Reform
  • 8/28/2018I-Mab Approved to Initiate Clinical Study of Genexine’s Diabetes Drug
  • 8/28/2018BeiGene Announces CNDA Acceptance of its First NDA for Zanubrutinib
  • 8/28/2018China Biologic Turns Down Buyout Proposal from CEO-led Consortium
  • 8/27/2018Harbour BioMed Raises $85M in Series B Financing to Accelerate Its Inn...
  • 8/27/2018FT: China Health Reforms Help Global Pharma Groups Despite Price Cuts?
  • 8/24/2018CNDA Solicits Comments on Draft Document for Infrastructural Building ...
  • 8/24/2018Recent Executive Moves
  • 8/24/2018USFDA Approves IND of Frontier Biotech's Novel Long-acting, All-inject...
  • 8/24/2018AstraZeneca Granted Chinese Approval for Its Ovarian Cancer Drug Lynpa...
  • 8/24/2018CDH-backed Mabpharm Files for Hong Kong IPO
  • 8/24/2018One More Senior NMPA Official under Investigation for Serious Violatio...
  • 8/23/2018Chinese Government Issues Notice for Correction of Pharma and Medical ...
  • 8/22/2018Reuters: Nasdaq-listed Zai Lab Eyes Hong Kong Float
  • Page:311/774 Total number of articles:23207: [First][<<] [309] [310] [311] [312] [313] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group